Inventor · disambiguated record
Kevin Eng
Also filed as: ENG KEVIN · ENG KEVIN HASEGAWA
3 granted patents·8 pending applications·2 citations·filing 2003–2016
54Inventor score
Files withGERON CORP3CAPRION PHARMACEUTICALS2WISCONSIN ALUMNI RES FOUND2CAPRION PHARMACEUTICALS INC1FILGUEIRA MARCELO1
Top patents by PatentIndex Score
11 records- 0172US9200327B2Diagnostic markers for treating cell proliferative disorders with telomerase inhibitorsGERON CORP·Filed 2013·Granted Dec 1, 2015·1 cites·30 claims
- 0270US9951389B2Diagnostic markers for treating cell proliferative disorders with telomerase inhibitorsGERON CORP·Filed 2015·Granted Apr 24, 2018·1 cites·15 claims
- 0364US2004172200A1Constellation mapping and uses thereofFiled 2003·Application pending·0 cites
- 0460US2006269945A1Constellation mapping and uses thereofCAPRION PHARMACEUTICALS·Filed 2006·Application pending·0 cites
- 0558US2006122785A1Constellation mapping and uses thereofCAPRION PHARMACEUTICALS·Filed 2005·Application pending·0 cites
- 0645US10167516B2Six-gene biomarker of survival and response to platinum based chemotherapy in serious ovarian cancer patientsWISCONSIN ALUMNI RES FOUND·Filed 2016·Granted Jan 1, 2019·0 cites·10 claims
- 0745US2015344963A1Diagnostic markers for treating cell proliferative disorders with telomerase inhibitorsGERON CORP·Filed 2013·Application pending·0 cites
- 0845US2014314750A1Six-Gene Biomarker of Survival and Response to Platinum Based Chemotherapy in Serious Ovarian Cancer PatientsWISCONSIN ALUMNI RES FOUND·Filed 2014·Application pending·0 cites
- 0941US2010183630A1Tat-005 and Methods of Assessing and Treating CancerFILGUEIRA MARCELO·Filed 2006·Application pending·0 cites
- 1040US2006287834A1Virtual mass spectrometryKEARNEY PAUL E·Filed 2006·Application pending·0 cites
- 1133US2007106065A1TAT- 001 and methods of assessing and treating cancerCAPRION PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin Eng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →